All sera were screened for antibodies against voltage-gated potassium channels (VGKC), voltage-gated calcium channels (VGCC), glutamic acid decarboxylase (GAD), N-methyl-D-aspartate receptor (NMDAR), and glycine receptor (GlyR) and compared to sera from healthy and disease controls (n = 160).